The Bacterial Zinc‐Metallophospholipases C

References

• Altemeier W. A., Furste W. L., Culbertson W. R., Wadsworth C. L., Tytell A. A., Logan M. A., Tytell A. G. Toxoid immunization in experimental gas gangrene. Ann. Surg. 1947; 126: 509
   Web of Science ®Google Scholar
• Alvarez A., Rives S., Nomdedeu B., Pereira A. Massive hemolysis in Clostridium perfringens infection. Haematologica 1999; 84: 571–573, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Annett C. B., Viste J. R., Chirino‐Trejo M., Classen H. L. Necrotic enteritis: effect of barley, wheat and corn diets on proliferation of Clostridium perfringens type A. Avian Pathol. 2002; 31: 599–602, [CROSSREF]
   Web of Science ®Google Scholar
• Asmuth D. M., Olson R. D., Hackett S. P., Bryant A. E., Tweten R. K., Tso J. Y., Zollman T., Stevens D. L. Effects of Clostridium perfringens recombinant and crude phospholipase C and theta‐toxin on rabbit hemodynamic parameters. J. Infect. Dis. 1995; 172: 1317–1323, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Awad M. M., Bryant A. E., Stevens D. L., Rood J. I. Virulence studies on chromosomal alpha‐toxin and theta‐toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of alpha‐toxin in Clostridium perfringens‐mediated gas‐gangrene. Mol. Microbiol. 1995; 15: 191–202, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Baba E., Fuller A. L., Gilbert J. M., Thayer S. G., McDougald L. R. Effects of Eimeria brunetti infection and dietary zinc on experimental induction of necrotic enteritis in broiler chickens. Avian Dis. 1992; 36: 59–62, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Barzaghi G., Cerletti C., Degaetano G. Phospholipase C from Clostridium perfringens induces human platelet aggregation in plasma. Thromb. Haemost. 1988; 59: 236–239, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Basak A. K., Stuart D. I., Nikura T., Bishop D. H.L., Kelly D. C., Fearn A., Titball R. W. Purification, crystallization and preliminary x‐ray diffraction studies of alpha‐toxin of Clostridium perfringens. J. Mol. Biol. 1994; 244: 648–650, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Basak A. K., Howells A., Eaton J. T., Moss D. S., Naylor C. E., Miller J., Titball R. W. Crystallization and preliminary x‐ray diffraction studies of a‐toxin from two different strains (NCTC8237 and CER89L43) of Clostridium perfringens. Acta Crystallogr., D Biol. Crystallogr. 1998; 54: 1425–1428, [CROSSREF]
   PubMedGoogle Scholar
• Bernheimer A. W., Avigad L. S., Kim K. S. Staphylococcal sphingomyelinase (beta‐hemolysin). Ann. N. Y. Acad. Sci. 1974; 236: 292–305, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Berridge M. J. Inositol triphosphate and diacylglycerol: two interacting secondary messengers. Ann. Rev. Biochem. 1987; 56: 159–193, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Boethius J., Rydqvist B., Mollby R., Wadstrom T. Effect of a highly purified phospholipase C on on some electrophysiological properties of the frog muscle fibre membrane. Life Sci. 1973; 13: 171–176, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Brennan J., Bagg R., Barnum D., Wilson J., Dick P. Efficacy of narasin in the prevention of necrotic enteritis in broiler chickens. Avian Dis. 2001; 45: 210–214, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bryant A., Stevens D. Phospholipase C and perfringolysin O from Clostridium perfringens up‐regulate endothelial cell adherence moloecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin‐8 synthesis in cultured human umbilical vein endothelial cells. Infect. Immun. 1996; 64: 358–362, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Bryant A. E., Chen R. Y.Z., Nagata Y., Wang Y., Lee C. H., Finegold S., Guth P. H., Stevens D. L. Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. J. Infect. Dis. 2000a; 182: 799–807, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bryant A. E., Chen R. Y.Z., Nagata Y., Wang Y., Lee C. H., Finegold S., Guth P. H., Stevens D. L. Clostridial gas gangrene. II. Phospholipase C‐induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. J. Infect. Dis. 2000b; 182: 808–815, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bryant A. E., Bayer C. R., Hayes‐Schroer S. M., Stevens D. L. Activation of platelet gpIIbIIIa by phospholipase C from Clostridium perfringens involves store‐operated calcium entry. J. Infect. Dis. 2003; 187: 408–417, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bullifent H. L., Moir A., Awad M. M., Scott P. T., Rood J. I., Titball R. W. The level of expression of alpha‐toxin by different strains of Clostridium perfringens is dependent on differences in promoter structure and genetic background. Anaerobe 1996; 2: 365–371, [CROSSREF]
   Web of Science ®Google Scholar
• Bunting M., Lorant D. E., Bryant A. E., Zimmerman G. A., McIntyre T. M., Stevens D. L., Prescott S. M. Alpha‐toxin from Clostridium perfringens induces proinflammatory changes in endothelial cells. J. Clin. Invest. 1997; 100: 565–574, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Carter G., White P., Fernie M., King S., McLean G., Titball R., Carr F. J. Enhanced antitumour effect of liposomal daunorubicin using antibody‐phospholipase C conjugates or fusion protein. Int. J. Oncol. 1998; 13: 819–825, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Chovnick A., Schneider W. P., Tso J. Y., Queen C., Chang C. N. A recombinant membrane acting immunotoxin. Cancer Res. 1991; 51: 465–467, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Christiansson A., Kuypers F. A., Roelofsen B., Op Den Kamp J. A.F., van Deenen L. L.M. Lipid molecular shape affects erythrocyte morphology: a study involving replacement of native phosphatidylcholine with different species followed by treatment of cells with sphingomyelinase C or phospholipase A2. J. Cell. Biol. 1985; 101: 1455–1462, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Clark G. C., Briggs D. C., Karasawa T., Wang X., Cole A. R., Maegawa T., Jayasekera P. N., Naylor C. E., Miller J., Moss D. S., Nakamura S., Basak A. K., Titball R. W. Clostridium absonum alpha‐toxin: new insights into clostridial phospholipase C substrate binding and specificity. J. Mol. Biol. 2003; 333: 759–769, submitted [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Eaton J. T., Naylor C. E., Howells A. M., Moss D. S., Titball R. W., Basak A. K. Crystal structure of the C. perfringens alpha‐toxin with the active site closed by a flexible loop region. J. Mol. Biol. 2002; 319: 275–281, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• El‐Sayed M. Y., DeBose C. D., Coury L. A., Roberts M. F. Sensitivity of phospholipase C (Bacillus cereus) activity to phosphatidylcholine structural modifications. Biochim. Biophys. Acta. 1985; 837: 325–335
   PubMed Web of Science ®Google Scholar
• Exton J. H. Signalling through phosphatidylcholine breakdown. 1990; 265: 1–4
   Google Scholar
• Flores‐Diaz M., Alape‐Giron A., Titball R. W., Moos M., Guillouard I., Cole S., Howells A. M., von Eichel‐Streiber C., Florin I., Thelestam M. UDP‐glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C. J. Biol. Chem. 1998; 273: 24433–24438, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fujii Y., Sakurai J. Contraction of the rat isolated aorta caused by Clostridium perfringens alpha toxin (phospholipase‐C)—evidence for the involvement of arachidonic acid metabolism. Br. J. Pharmacol. 1989; 97: 119–124, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fujii Y., Nomura S., Oshita Y., Sakurai J. Excitatory effect of Clostridium perfringens alpha‐toxin on the rat isolated aorta. Br. J. Pharmacol. 1986a; 88: 531–539, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Fujii Y., Shirotani M., Sakurai J. Effect of Clostridium perfringens alpha‐toxin on rabbit platelets. Jpn. J. Med. Sci. Biol. 1986b; 39: 244–245
   Google Scholar
• Geoffroy C., Raveneau J., Beretti J. L., Lecroisey A., Vazquez‐Boland J. A., Alouf J. E., Berche P. Purification and characterization of an extracellular 29‐kilodalton phospholipase‐C from Listeria monocytogenes. Infect. Immun. 1991; 59: 2382–2388, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gillmor S. A., Villaseñor A., Fletterick R., Sigal E., Browner M. F. The structure of mammalian 15‐lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity. Nature Struct. Biol 1997; 4: 1003–1009, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Gilmore M. S., Cruzrodz A. L., Leimeisterwachter M., Kreft J., Goebel W. A Bacillus cereus cytolytic determinant, cereolysin‐AB, which comprises the phospholipase C and sphingomyelinase genes—nucleotide sequence and genetic linkage. J. Bacteriol. 1989; 171: 744–753, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ginter A., Williamson E. D., Dessy F., Coppe P., Bullifent H., Howells A., Titball R. W. Molecular variation between the alpha‐toxins from the type strain (NCTC 8237) and clinical isolates of Clostridium perfringens associated with disease in man and animals. Microbiology (UK) 1996; 142: 191–198
   PubMed Web of Science ®Google Scholar
• Gubash S. M. Improved egg‐yolk agar plate medium for the detection of Clostridial phospholipase‐C activity. Res. Microbiol. 1991; 142: 87–93, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Guillouard I., Garnier T., Cole S. T. Use of site‐directed mutagenesis to probe structure‐function relationships of alpha‐toxin from Clostridium perfringens. Infect. Immun. 1996; 64: 2440–2444, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Gustafson C., Tagesson C. Phospholipase‐C from Clostridium perfringens stimulates phospholipase‐A2‐mediated arachidonic acid release in cultured intestinal epithelial cells (Int‐407). Scand. J. Gastroenterol. 1990; 25: 363–371, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Heier B. T., Lovland A., Soleim K. B., Kaldhusdal M., Jarp J. A field study of naturally occurring specific antibodies against Clostridium perfringens alpha toxin in Norwegian broiler flocks. Avian Dis. 2001; 45: 724–732, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Hough E., Hansen L. K., Birkness B., Jynge K., Hansen S., Hordik A., Little C., Dodson E., Derewenda Z. High resolution (1.5A) crystal structure of phospholipase C from Bacillus cereus. Nature 1989; 338: 357–360, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hubl W., Mostbeck B., Hartleb H., Pointner H., Kofler K., Bayer P. M. Investigation of the pathogenesis of massive hemolysis in a case of Clostridium perfringens septicemia. Ann. Hematol. 1993; 67: 145–147, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jepson M., Howells A., Bullifent H. L., Bolgiano B., Crane D., Miller J., Holley J., Jayasekera P., Titball R. W. Differences in the carboxy‐terminal (putative phospholipid binding) domains of Clostridium perfringens and Clostridium bifermentans phospholipases C influence the hemolytic and lethal properties of these enzymes. Infect. Immun. 1999; 67: 3297–3301, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Jepson M., Bullifent H. L., Crane D., Flores‐Diaz M., Alape‐Giron A., Jayasekeera P., Lingard B., Moss D., Titball R. W. Tyrosine 331 and phenylalanine 334 in Clostridium perfringens alpha‐toxin are essential for cytotoxic activity. FEBS Lett. 2001; 495: 172–177, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Johansen T., Holm T., Guddal P. H., Sletten K., Haugli F. B., Little C. Cloning and sequencing of the gene encoding the phosphatidylcholine‐preferring phospholipase C of Bacillus cereus. Gene 1988; 65: 293–304, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Justin N., Walker N., Bullifent H. L., Songer G., Bueschel D. M., Jost H., Naylor C., Miller J., Moss D. S., Titball R. W., Basak A. K. The first strain of Clostridium perfringens isolated from an avian source has an alpha‐toxin with divergent structural and kinetic properties. Biochemistry 2002; 41: 6253–6262, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kaldhusdal M., Hofshagen M., Lovland A., Langstrand H., Redhead K. Necrotic enteritis challenge models with broiler chickens raised on litter: evaluation of preconditions, Clostridium perfringens strains and outcome variables. FEMS Immunol. Med. Microbiol. 1999; 24: 337–343, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kameyama K., Matsushita O., Katayama S., Minami J., Maeda M., Nakamura S., Okabe A. Analysis of the phospholipase C gene of Clostridium perfringens KZ1340 isolated from Antarctic soil. Microbiol. Immunol. 1996; 40: 255–263, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Karasawa T., Wang X. M., Maegawa T., Michiwa Y., Kita H., Miwa K., Nakamura S. Clostridium sordellii phospholipase C: gene cloning and comparison of enzymatic and biological activities with those of Clostridium perfringens and Clostridium bifermentans phospholipase C. Infect. Immun. 2003; 71: 641–646, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Katayama S., Matsushita O., Minami J., Mizobuchi S., Okabe A. Comparison of the alpha toxin genes of Clostridium perfringens type‐A and type‐C strains—evidence for extragenic regulation of transcription. Infect. Immun. 1993; 61: 457–463, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Krug E. L., Kent C. Phospholipase C from Clostridium perfringens: preparation and characterisation of homogenous enzyme. 1984; 231: 400–410
   Google Scholar
• Kurioka S., Matsuda M. Phospholipase C assay using p‐nitrophenolphosphorylcholine and its application to studying the metal and detergent requirement of the enzyme. Anal. Biochem. 1976; 75: 281–289, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lim S. J., Koh U. C., Lee E. O., Kim C. K. Liposome‐based assay for phospholipase C. Bull. Korean Chem. Soc. 1997; 18: 761–766
   Web of Science ®Google Scholar
• Little C., Aurebekk B., Otnaess A.‐B. Purification by affinity chromatography of phospholipase C from Bacillus cereus. FEBS Lett. 1975; 52: 175–179, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• MacFarlane M. G., Knight B. C.J.G. The biochemistry of bacterial toxins I Lecithinase activity of Cl welchii toxins. 1941; 35: 884–902
   Google Scholar
• MacLennan J. D. The histotoxic clostridial infections of man. Bacteriol. Rev. 1962; 26: 177–276, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• MacLennan J. D., MacFarlane M. G. The treatment of gas gangrene. Br. Med. J. 1944; 683
   PubMedGoogle Scholar
• Manteca C., Daube G., Pirson V., Limbourg B., Kaeckenbeeck A., Mainil J. G. Bacterial intestinal flora associated with enterotoxaemia in Belgian Blue calves. Vet. Microbiol. 2001; 81: 21–32, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• McNee J. W., Dunn J. S. The method of spread of gas gangrene into living muscle. 1917; 1: 727–729
   Google Scholar
• Mollby R. Bacterial phospholipases. Bacterial Toxins and Cell Membranes, J. Jeljaszewicz, T. Wadstrom. Academic Press, London 1978; 367–424
   Google Scholar
• Moolten F. L., Achreiber B. M., Zadjel S. H. Antibodies conjugated to potent cytotoxins as specific antitumour agents. Immunol. Rev. 1982; 62: 47–73, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Moreau H., Pieroni G., Jolivetreynaud C., Alouf J. E., Verger R. A new kinetic approach for studying phospholipase‐C (Clostridium perfringens alpha toxin) activity on phospholipid monolayers. Biochemistry 1988; 27: 2319–2323, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Murrell T. G.C., Murrell W. G., Lindsay J. A. Sudden‐infant‐death‐syndrome (Sids)—are common bacterial toxins responsible, and do they have a vaccine potential. Vaccine 1994; 12: 365–368, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nagahama M., Sakurai J. Threonine‐74 is a key site for the activity of Clostridium perfringens alpha‐toxin. Microbiol. Immunol. 1996; 40: 189–193, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nagahama M., Ochi S., Kobayashi K., Sakurai J. The relationship between histidine residues and various biological activities of Clostridium perfringens alpha‐toxin. Abstr. Pap.‐Am. Chem. Soc. 1995; 209: 75‐AGFD
   Web of Science ®Google Scholar
• Nagahama M., Michiue K., Sakurai J. Membrane‐damaging action of Clostridium perfringens alpha‐toxin on phospholipid liposomes. Biochim. Biophys. Acta, Biomembr. 1996a; 1280: 120–126, [CROSSREF]
   Web of Science ®Google Scholar
• Nagahama M., Michiue K., Kobayashi K., Sakurai J. Effect of Clostridium perfringens alpha‐toxin on phospholipid‐cholesterol liposomes. Jpn. J. Med. Sci. Biol. 1996b; 49: 249–250
   Google Scholar
• Nagahama M., Nakayama T., Michiue K., Sakurai J. Site‐specific mutagenesis of Clostridium perfringens alpha‐toxin: replacement of Asp‐56, Asp‐130, or Glu‐152 causes loss of enzymatic and hemolytic activities. Infect. Immun. 1997; 65: 3489–3492, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nagahama W., Mukai M., Ochi S., Sakurai J. Role of tryptophan‐1 in hemolytic and phospholipase C activities of Clostridium perfringens alpha‐toxin. Microbiol. Immunol. 2000; 44: 585–589, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nagahama M., Mukai M., Morimitsu S., Ochi S., Sakurai J. Role of the C‐domain in the biological activities of Clostridium perfringens alpha‐toxin. Microbiol. Immunol. 2002; 46: 647–655, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nalefski E. A., Falke J. J. The C2 domain calcium binding motif: structural and functional diversity. Protein Sci. 1996; 12: 2375–2390
   Google Scholar
• Naylor C. E., Eaton J. T., Howells A., Justin N., Moss D. S., Titball R. W., Basak A. K. Structure of the key toxin in gas gangrene. Nat. Struct. Biol. 1998; 5: 738–746, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Naylor C. E., Jepson M., Crane D. T., Titball R. W., Miller J., Basak A. K., Bolgiano B. Characterisation of the calcium‐binding C‐terminal domain of Clostridium perfringens alpha‐toxin. J. Mol. Biol. 1999; 294: 757–770, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ninomiya M., Matsushita O., Minami J., Sakamoto H., Nakano M., Okabe A. Role of alpha‐toxin in Clostridium perfringens infection determined by using recombinants of Clostridium perfringens and Bacillus subtilis. Infect. Immun. 1994; 62: 5032–5039, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nishizuka Y. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 1992; 258: 607–614, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Ochi S., Hashimoto K., Nagahama M., Sakurai J. Hemolysis and phospholipid metabolism elicited by Clostridium perfringens alpha‐toxin through activation of GTP‐binding protein in rabbit erythrocytes. Jpn. J. Med. Sci. Biol. 1996; 49: 266–267
   Google Scholar
• Ochi S., Miyawaki T., Matsuda H., Oda M., Nagahama M., Sakurai J. Clostridium perfringens alpha‐toxin induces rabbit neutrophil adhesion. Microbiology (UK) 2002; 148: 237–245
   PubMed Web of Science ®Google Scholar
• Ohsaka A., Tsuchiya M., Oshio C., Miyaira M., Suzuki K., Yamkawa Y. Aggregation of platelets in the micro‐circulation of the rat induced by the alpha‐toxin (phospholipase C) of Clostridium perfringens. 1978; 16: 333–341
   Google Scholar
• Otnaess A.‐B. The hydrolysis of sphingomyelin by phospholipase C from Bacillus cereus. FEBS Lett. 1980; 114: 202–204, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Otnaess A.‐B., Little C., Sletten K., Wallin R., Johnsen S., Flensgrud R., Prydz H. Some characteristics of phospholipase C from Bacillus cereus. Eur. J. Biochem. 1977; 79: 459–468, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Perisic O., Fong S., Lynch D. E., Bycroft M., Williams R. L. Crystal structure of a calcium‐phospholipid binding domain from cytosolic phospholipase A2. J. Biol. Chem. 1998; 273: 1596–1604, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pons J. L., Ageron E., Mangeney N., Tessedre A. C., Niel P., Leluan G., Grimont P. A.D. Genetic relationships of Clostridium bifermentans and Clostridium sordellii analyzed by multilocus enzyme electrophoresis and DNA–DNA hybridization. Syst. Appl. Microbiol. 1997; 20: 381–386
   Web of Science ®Google Scholar
• Ponting C. P., Parker P. J. Extending the C2 domain family: C2s in PKCs d, e, h, q, phospholipases, GAPs, and perforin. Protein Sci. 1996; 5: 162–166, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Riddell C., Kong X. M. The influence of diet on necrotic enteritis in broiler‐chickens. Avian Dis. 1992; 36: 499–503, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Robertson M., Keppie J. Active immunisation for gas gangrene. 1943; II: 311
   Google Scholar
• Roelofsen B., Op Den Kamp J. A.F. Chemical and enzymatic localisation of phospholipids in biological membranes. Tech. Lipid Membr. Biochem. 1982; B413: 1–28
   Google Scholar
• Saintjoanis B., Garnier T., Cole S. T. Gene cloning shows the alpha‐toxin of Clostridium perfringens to contain both sphingomyelinase and lecithinase activities. Mol. Gen. Genet. 1989; 219: 453–460, [CROSSREF]
   PubMedGoogle Scholar
• Sakurai J., Fujii Y., Shirotani M. Contraction induced by Clostridium perfringens alpha toxin in the isolated rat ileum. Toxicon 1990; 28: 411–418, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sakurai J., Tsuchiya Y., Ochi S., Fujii Y. Effect of Clostridium perfringens alpha‐toxin on contraction of isolated guinea‐pig diaphragm. Microbiol. Immunol. 1991; 35: 481–486, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sakurai J., Ochi S., Tanaka H. Evidence for coupling of Clostridium perfringens alpha‐toxin induced hemolysis to stimulated phosphatidic acid formation in rabbit erythrocytes. Infect. Immun. 1993; 61: 3711–3718, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sakurai J., Ochi S., Tanaka H. Regulation of Clostridium perfringens alpha‐toxin activated phospholipase‐C in rabbit erythrocyte membranes. Infect. Immun. 1994; 62: 717–721, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983; 220: 568–575, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Sato H., Yamakawa Y., Ito A., Murata R. Effect of zinc and calcium ions on the production of alpha‐toxin and proteases by Clostridium perfringens. Infect. Immun. 1978; 20: 325–333, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Schmid M., Walcher M., Bubert A., Wagner M., Schleifer K. H. Nucleic acid based, cultivation independent detection of Listeria spp. and genotypes of L. monocytogenes. FEMS Immunol. Med. Microbiol 2003; 35: 215–225, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Schoepe H., Pache C., Neubauer A., Potschka H., Schlapp T., Wieler L. H., Baljer G. Naturally occurring Clostridium perfringens nontoxic alpha‐toxin variant as a potential vaccine candidate against alpha‐toxin‐associated diseases. Infect. Immun. 2001; 69: 7194–7196, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shao X., Daveltov B. A., Sutton R. B., Südhof T. C., Rizo J. Bipartite Ca2 + ‐binding motif in C2 domains of synaptotagmin and protein kinase C. Science 1996; 273: 248–251, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Siarakas S., Damas E., Murrell W. G. Is cardiorespiratory failure induced by bacterial toxins the cause of sudden‐infant‐death‐syndrome—studies with an animal model (the rabbit). Toxicon 1995; 33: 635–649, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Smith G. A., Marquis H., Jones S., Johnston N. C., Portnoy D. A., Goldfine H. The two distinct phospholipase C of Listeria monocytogenes have overlapping roles in escape from a vacuole and cell‐to‐cell spread. Infect. Immun. 1995; 63: 4231–4237, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stevens D. L., Bryant A. E. Pathogenesis of Clostridium perfringens infections: mechanisms and mediators of shock. Clin. Infect. Dis. 1997; 25: S160–S164, [PUBMED], [INFOTRIEVE]
   Web of Science ®Google Scholar
• Stevens D. L., Tweten R. K., Awad M. M., Rood J. I., Bryant A. E. Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis. J. Infect. Dis. 1997; 176: 189–195, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stevens D. L., Titball R. W., Jepson M., Bayer C., Schroer S., Bryant A. E. Immunization with C‐domain of alpha‐toxin prevents lethal infection, localises tissue injury and promotes host response to challenge with viable Clostridium perfringens. J. Clin. Microbiol. 2003, submitted
   PubMedGoogle Scholar
• Sugahara T., Takahashi T., Yamaya S., Ohsaka A. In vitro aggregation of platelets induced by alpha‐toxin (phospholipase C) of Clostridium perfringens. 1977; 29: 255–263
   Google Scholar
• Sutton R. B., Sprang S. R. Structure of the protein kinase Cb phospholipid‐binding C2 domain complexed with Ca2 +. Structure 1998; 6: 1395–1405, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Synder W. R. A continuous spectrophotometric assay for the Bacillus cereus phospholipase C using a thiophosphate analog: evaluation of assay conditions and chromogenic agents. Anal. Biochem. 1987; 164: 199–206, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Taguchi R., Ikezawa H. Phospholipase C from Clostridium novyi type A.I. Biochim. Biophys. Acta 1975; 409: 75–85, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Takahashi T., Sugahara T., Ohsaka A. Phospholipase C from Clostridium perfringens. Methods Enzymol. 1981; 71: 710–725, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Titball R. W., Rubidge T. The role of histidine residues in the alpha toxin of Clostridium perfringens. FEMS Microbiol. Lett. 1990; 68: 261–265
   Web of Science ®Google Scholar
• Titball R. W., Hunter S. E.C., Martin K. L., Morris B. C., Shuttleworth A. D., Rubidge T., Anderson D. W., Kelly D. C. Molecular cloning and nucleotide sequence of the alpha‐toxin (phospholipase‐C) of Clostridium perfringens. Infect. Immun. 1989; 57: 367–376, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Titball R. W., Leslie D. L., Harvey S., Kelly D. Hemolytic and sphingomyelinase activities of Clostridium perfringens alpha‐toxin are dependent on a domain homologous to that of an enzyme from the human arachidonic acid pathway. Infect. Immun. 1991; 59: 1872–1874, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Titball R. W., Fearn A. M., Williamson E. D. Biochemical and immunological properties of the C‐terminal domain of the alpha‐toxin of Clostridium perfringens. FEMS Microbiol. Lett. 1993; 110: 45–50, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Titball R. W., Naylor C. E., Miller J., Moss D. S., Basak A. K. Opening of the active site of Clostridium perfringens alpha‐toxin may be triggered by membrane binding. Int. J. Med. Microbiol. 2000; 290: 357–361, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tsai I. K., Yen M. Y., Ho I. C., Yu K. W., Liu C. Y., Cheng D. L. Clostridium perfringens septicemia with massive hemolysis. Scand. J. Infect. Dis. 1989; 21: 467–471, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tso J. Y., Siebel C. Cloning and expression of the phospholipase‐C gene from Clostridium perfringens and Clostridium bifermentans. Infect. Immun. 1989; 57: 468–476, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Tsutsui K., Minami J., Matsushita O., Katayama S., Taniguchi Y., Nakamura S., Nishioka M., Okabe A. Phylogenetic analysis of phospholipase‐C genes from Clostridium perfringens Type‐A to Type‐E and Clostridium novyi. J. Bacteriol. 1995; 177: 7164–7170, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• van Deenen L. L.M., Demel R. A., Guerts van Kessel W. S.M., Kamp H. H., Roelofsen B., Verkleij A. J., Wirtz K. W.A., Zwaal R. F.A. Phospholipases and monolayers as tools in studies on membrane structure. The Structural Basis of Membrane Function, Y. Hatefi, L. Djavadi‐Ohaniance. Academic Press, New York 1976; 21–38
   Google Scholar
• Vazquez‐Boland J.‐A., Kocks C., Dramsi S., Ohayon H., Geoffroy C., Mengaud J., Cossart P. Nucleotide sequence of the lecithinase operon of Listeria monocytogenes and possible role of lecithinase in cell–cell spread. Infect. Immun. 1992; 60: 219–230
   PubMed Web of Science ®Google Scholar
• Vazquez‐Boland J.‐A., Kuhn M., Berche P., Chakraborty T., Dominquez‐Bernal G., Goebel W., Gonzalez‐Zorn B., Wehland J., Kreft J. Listeria pathogenesis and molecular virulence determinants. Clin. Microbiol. Rev. 2001; 14: 584–640, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Verkleij A. J., Zwaal R. F.A., Roelofsen B., Comfurius P., Kastelijn D., van Deenen L. L.M. The asymmetric distribution of phospholipids in the human red cell membrane. A combined study using phospholiases and freeze‐etch electron microscopy. 1973; 323: 178–193
   Google Scholar
• Verma N. D. Immune response in calves to the use of Clostridium perfringens Type A vaccine. Indian J. Anim. Sci. 1987; 57: 977–979
   Web of Science ®Google Scholar
• Waite M. Handbook of Lipid Research 5. The Phospholipases. Plenum Press, New York 1987
   Google Scholar
• Walker N., Holley J., Naylor C. E., Flores‐Diaz M., Alape‐Giron A., Carter G., Carr F. J., Thelestam M., Keyte M., Moss D. S., Basak A. K., Miller J., Titball R. W. Identification of residues in the carboxy‐terminal domain of Clostridium perfringens alpha‐toxin (Phospholipase C) which are required for its biological activities. Arch. Biochem. Biophys. 2000; 384: 24–30, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wierup M. The Swedish experience of the 1986 year ban of antimicrobial growth promoters, with special reference to animal health, disease prevention, productivity, and usage of antimicrobials. Microb. Drug Resist. Mech. Epidemiol. Dis. 2001; 7: 183–190
   PubMed Web of Science ®Google Scholar
• Williamson E. D., Titball R. W. A genetically engineered vaccine against the alpha‐toxin of Clostridium perfringens protects mice against experimental gas‐gangrene. Vaccine 1993; 11: 1253–1258, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar